Testing an Eye-Movement Vision Test for People With Tumors Near the Pituitary Gland
Official title: Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on .
The short version
This study is checking whether a vision test called SONDA, which follows your eye movements, works well for people with a tumor in the area above the pituitary gland.
Read our full plain-language summary
What the trial team says
The purpose of this study is to assess wether the SONDA visual field test is suitable for patients with a supra sellar tumour.
Key facts
- Registry number
- NCT06266949
- Conditions studied
- Pituitary Tumor, Visual Fields Hemianopsia
Where it is running
This trial lists 1 site.
-
Provincie Groningen
- UMCG (Groningen)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.